Importantly, activation of STAT3 signalling has been found to induce a switch from the less aggressive proneural to the more aggressive mesenchymal tumour subtype associated with chemoradiotherapy-resistance and recurrence in GBM [71]. Here, STAT3 is linked to neoplasm.